Protalix BioTherapeutics Inc (PLX)
1.335
+0.08
(+6.80%)
USD |
NYAM |
Nov 04, 13:13
Protalix BioTherapeutics Enterprise Value: 67.32M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 67.32M |
| October 31, 2024 | 61.44M |
| October 30, 2024 | 61.44M |
| October 29, 2024 | 61.44M |
| October 28, 2024 | 58.49M |
| October 25, 2024 | 54.82M |
| October 24, 2024 | 51.14M |
| October 23, 2024 | 50.40M |
| October 22, 2024 | 53.35M |
| October 21, 2024 | 53.35M |
| October 18, 2024 | 55.55M |
| October 17, 2024 | 55.55M |
| October 16, 2024 | 55.55M |
| October 15, 2024 | 54.82M |
| October 14, 2024 | 53.35M |
| October 11, 2024 | 54.82M |
| October 10, 2024 | 48.93M |
| October 09, 2024 | 49.67M |
| October 08, 2024 | 50.40M |
| October 07, 2024 | 50.40M |
| October 04, 2024 | 54.82M |
| October 03, 2024 | 49.67M |
| October 02, 2024 | 50.40M |
| October 01, 2024 | 52.61M |
| September 30, 2024 | 50.40M |
| Date | Value |
|---|---|
| September 27, 2024 | 52.61M |
| September 26, 2024 | 54.08M |
| September 25, 2024 | 55.55M |
| September 24, 2024 | 54.82M |
| September 23, 2024 | 57.76M |
| September 20, 2024 | 56.29M |
| September 19, 2024 | 59.97M |
| September 18, 2024 | 55.55M |
| September 17, 2024 | 56.29M |
| September 16, 2024 | 55.55M |
| September 13, 2024 | 52.61M |
| September 12, 2024 | 53.35M |
| September 11, 2024 | 51.88M |
| September 10, 2024 | 50.40M |
| September 09, 2024 | 49.67M |
| September 06, 2024 | 48.93M |
| September 05, 2024 | 50.40M |
| September 04, 2024 | 49.67M |
| September 03, 2024 | 54.08M |
| August 30, 2024 | 44.83M |
| August 29, 2024 | 42.32M |
| August 28, 2024 | 41.58M |
| August 27, 2024 | 42.42M |
| August 26, 2024 | 43.05M |
| August 23, 2024 | 46.56M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
19.45M
Minimum
Dec 03 2021
274.11M
Maximum
Feb 24 2021
91.24M
Average
82.08M
Median
Nov 15 2023
Enterprise Value Benchmarks
| Aethlon Medical Inc | -3.712M |
| Predictive Oncology Inc | -0.4523M |
| bluebird bio Inc | 16.14M |
| AIM ImmunoTech Inc | 9.109M |
| Armata Pharmaceuticals Inc | 170.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.203M |
| Revenue (Quarterly) | 13.47M |
| Total Expenses (Quarterly) | 15.90M |
| EPS Diluted (Quarterly) | -0.03 |
| Gross Profit Margin (Quarterly) | 29.82% |
| Profit Margin (Quarterly) | -16.35% |
| Earnings Yield | -17.23% |
| Normalized Earnings Yield | -17.23 |